Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study

被引：0
|
作者：
Ashina, Messoud [1 ]
Mitsikostas, Dimos D. [2 ]
Amin, Faisal M. [1 ,3 ]
Kokturk, Pinar [4 ]
Sahin, Gurdal [5 ]
Schankin, Christoph J. [6 ]
Dorman, Paul J. [7 ]
Pozo-Rosich, Patricia [8 ]
Lyras, Leonidas [4 ]
Myers, Coleen [9 ]
Ahn, Andrew H. [9 ]
Tassorelli, Cristina [10 ]
机构：
[1] Univ Copenhagen, Danish Headache Ctr, Rigshop, Copenhagen, Denmark
[2] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Athens, Greece
[3] Univ Copenhagen, Dept Neurorehabilitat Traumat Brain Injury, Righosp, Copenhagen, Denmark
[4] Teva Netherlands BV, Haarlem, Netherlands
[5] Lund Univ, Dept Clin Sci Lund, Skaneuro Neurol Clin, Lund, Sweden
[6] Univ Bern, Univ Hosp Bern, Inselspital, Bern, Switzerland
[7] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle, NSW, Australia
[8] Univ Autonoma Barcelona, Vall dHebron Hosp Res Inst, Headache Unit Res Grp, Barcelona, Spain
[9] Teva Branded Pharmaceut Prod R&D Inc, Malvern, PA USA
[10] Univ Pavia, IRCCS Mondino Fdn, Pavia, Italy
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202844
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P12-12.002
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Impact of fremanezumab on headache intensity and duration of remaining migraine attacks: PEARL 3rd interim analysis
    Tassorelli, C.
    Mitsikostas, D.
    Amin, F.
    Kokturk, P.
    Schankin, C.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A.
    Martins, I.
    Sumelahti, M.
    Krasenbaum, L.
    Ahn, A.
    Akcicek, H.
    Ashina, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 690 - 690
  • [22] Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine
    Winner, Paul K.
    Spierings, Egilius L. H.
    Yeung, Paul P.
    Aycardi, Ernesto
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    HEADACHE, 2019, 59 (10): : 1743 - 1752
  • [23] Fremanezumab adherence & persistence along with past & concomitant migraine medication use: PEARL 3rd interim analysis
    Tassorelli, C.
    Mitsikostas, D.
    Amin, F.
    Kokturk, P.
    Schankin, C.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A.
    Martins, I.
    Sumelahti, M.
    Krasenbaum, L.
    Ahn, A.
    Lyras, L.
    Ashina, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 689 - 689
  • [24] 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB AS PREVENTIVE TREATMENT IN CHRONIC AND EPISODIC MIGRAINE
    Smolen, L.
    Gandhi, S. K.
    Klein, T.
    Iyer, R.
    Thompson, S.
    Cohen, J. M.
    Lipton, R. B.
    VALUE IN HEALTH, 2019, 22 : S273 - S273
  • [25] 10-Year Cost-Effectiveness Analyses of Fremanezumab as Preventive Treatment in Chronic and Episodic Migraine
    Smolen, L.
    Gandhi, S. K.
    Klein, T.
    Iyer, R.
    Thompson, S.
    Cohen, J. M.
    Lipton, R. B.
    HEADACHE, 2019, 59 : 69 - 70
  • [26] Quarterly vs monthly fremanezumab for the preventive treatment of migraine, a real-life study
    Huerta Villanueva, Mariano
    Campoy, Sergio
    Munoz-Vendrell, Albert
    Campdelacreu, Jaume
    Prat, Joan
    CEPHALALGIA, 2023, 43 (1supp)
  • [27] Comparison study between erenumab, fremanezumab, and galcanezumab in the preventive treatment of high frequency episodic migraine and chronic migraine
    Simone Quintana
    Marco Russo
    Gian Camillo Manzoni
    Paola Torelli
    Neurological Sciences, 2022, 43 : 5757 - 5758
  • [28] Efficacy and tolerability of fremanezumab for migraine preventive treatment in Korean patients with chronic or episodic migraine
    Kim, Byung-Kun
    Cohen, Joshua
    Kim, Sukyung
    Chang, Daeho
    Ning, Xiaoping
    Lengil, Tamar
    Janka, Lindsay
    Barash, Steve
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 214 - 214
  • [29] Comparison study between erenumab, fremanezumab, and galcanezumab in the preventive treatment of high frequency episodic migraine and chronic migraine
    Quintana, Simone
    Russo, Marco
    Manzoni, Gian Camillo
    Torelli, Paola
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5757 - 5758
  • [30] Fremanezumab Effectiveness and Tolerability in Clinical Routine: Interim Real-World-Data of the Observational FINESSE Study
    Straube, Andreas
    Broessner, Gregor
    Gaul, Charly
    Hamann, Xenia
    Kraya, Torsten
    Neeb, Lars
    CEPHALALGIA, 2023, 43 (1supp) : 243 - 244
12345